196 related articles for article (PubMed ID: 19450979)
1. Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus.
Gamble C; Trotard M; Le Seyec J; Abreu-Guerniou V; Gernigon N; Berrée F; Carboni B; Felden B; Gillet R
Bioorg Med Chem Lett; 2009 Jul; 19(13):3581-5. PubMed ID: 19450979
[TBL] [Abstract][Full Text] [Related]
2. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
3. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
4. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
5. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
[TBL] [Abstract][Full Text] [Related]
6. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
7. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.
Kikuchi K; Umehara T; Fukuda K; Kuno A; Hasegawa T; Nishikawa S
Nucleic Acids Res; 2005; 33(2):683-92. PubMed ID: 15681618
[TBL] [Abstract][Full Text] [Related]
8. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
Gallego J; Varani G
Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.
Hoffman B; Liu Q
Liver Int; 2011 Nov; 31(10):1449-67. PubMed ID: 21745290
[TBL] [Abstract][Full Text] [Related]
12. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
[TBL] [Abstract][Full Text] [Related]
13. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163
[TBL] [Abstract][Full Text] [Related]
14. [Structure and function of the non-coding regions of hepatitis C viral RNA].
Dutkiewicz M; Swiqtkowska A; Ciesiołka J
Postepy Biochem; 2006; 52(1):62-71. PubMed ID: 16869303
[TBL] [Abstract][Full Text] [Related]
15. hnRNP L is required for the translation mediated by HCV IRES.
Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.
Li X; Mueller S; Wimmer E
Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092
[TBL] [Abstract][Full Text] [Related]
17. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
[TBL] [Abstract][Full Text] [Related]
18. A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins.
Rijnbrand R; Yang Y; Beales L; Bodola F; Goettge K; Cohen L; Lanford RE; Lemon SM; Martin A
Hepatology; 2005 May; 41(5):986-94. PubMed ID: 15793797
[TBL] [Abstract][Full Text] [Related]
19. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
Paek KY; Kim CS; Park SM; Kim JH; Jang SK
J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
[TBL] [Abstract][Full Text] [Related]
20. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR].
Wang XH; Wang SQ; Guan W; Mao BZ
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
